ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Community-Based Program Final Planning Review In August, October

August 6, 1976

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

In Brief: NCI Needs To Move Quicker On Funding Jot New Leads, Rauscher Says; Harley Dirks Quits

October 15, 1976

In Brief: Elion Elected Member Of National Academy; Bleyer Heads M.D. Anderson Pediatrics

May 4, 1990